CVS GROUP PLC

Transaction in Own Shares • Nov 11, 2025

National Storage Mechanism | Additional information

RNS Number : 9502G

CVS Group plc

11 November 2025

11 November 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 10 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	10/11/2025
Aggregate number of Ordinary Shares purchased:	23,628
Lowest price paid per share (GBp):	1,206.00
Highest price paid per share (GBp):	1,218.00
Volume weighted average price paid per share (GBp):	1,209.54

CVS intends to cancel all of the purchased Ordinary Shares.

Total voting rights:

Due to an administrative error, the issued share capital was incorrectly stated on 10/11/2025 in RNS number 8395G. Following adjusting for the administrative error, settlement of the above purchases and cancellation of the Ordinary Shares purchased and including any allotments that may have been made during the day relating to the exercising of employee shares options, the Company will have 71,409,567 Ordinary Shares in issue, each with one voting right. The Company holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,409,567 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 331,216 Ordinary Shares in aggregate at a weighted average price of 1,266.46 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
254	1214	10/11/2025 08:00:41	1330435455977728	XLON
231	1214	10/11/2025 08:04:22	1330435455978670	XLON
73	1214	10/11/2025 08:04:22	1330435455978671	XLON
72	1214	10/11/2025 08:20:52	1330435455980797	XLON
84	1218	10/11/2025 09:08:14	1330435455984910	XLON
81	1216	10/11/2025 09:09:16	1330435455985005	XLON
314	1214	10/11/2025 09:13:12	1330435455985397	XLON
239	1214	10/11/2025 09:13:12	1330435455985400	XLON
160	1212	10/11/2025 09:13:24	1330435455985411	XLON
88	1210	10/11/2025 09:13:54	1330435455985450	XLON
72	1212	10/11/2025 09:16:40	1330435455985630	XLON
124	1212	10/11/2025 09:17:00	1330435455985640	XLON
72	1216	10/11/2025 10:51:05	1330435455992013	XLON
72	1214	10/11/2025 10:56:45	1330435455992420	XLON
72	1216	10/11/2025 11:22:06	1330435455993762	XLON
72	1214	10/11/2025 11:45:25	1330435455995101	XLON
972	1212	10/11/2025 11:48:53	1330435455995373	XLON
220	1212	10/11/2025 11:55:03	1330435455995652	XLON
776	1212	10/11/2025 11:55:03	1330435455995653	XLON
731	1210	10/11/2025 12:38:10	1330435455998132	XLON
283	1210	10/11/2025 12:38:10	1330435455998133	XLON
463	1210	10/11/2025 12:49:16	1330435455998850	XLON
585	1210	10/11/2025 12:49:16	1330435455998851	XLON
1073	1208	10/11/2025 13:25:17	1330435456001570	XLON
1095	1210	10/11/2025 13:50:44	1330435456003374	XLON
6	1210	10/11/2025 13:50:44	1330435456003376	XLON
530	1210	10/11/2025 13:50:44	1330435456003377	XLON
417	1210	10/11/2025 13:50:44	1330435456003378	XLON
77	1208	10/11/2025 13:52:26	1330435456003427	XLON
221	1208	10/11/2025 14:06:05	1330435456004522	XLON
190	1208	10/11/2025 14:06:06	1330435456004526	XLON
408	1208	10/11/2025 14:34:26	1330435456008276	XLON
208	1208	10/11/2025 14:34:26	1330435456008279	XLON
114	1206	10/11/2025 14:34:38	1330435456008320	XLON
66	1206	10/11/2025 14:34:38	1330435456008321	XLON
72	1208	10/11/2025 14:51:22	1330435456011792	XLON
180	1206	10/11/2025 14:56:00	1330435456012663	XLON
334	1206	10/11/2025 14:56:00	1330435456012668	XLON
180	1206	10/11/2025 14:56:00	1330435456012671	XLON
596	1206	10/11/2025 14:56:00	1330435456012673	XLON
180	1206	10/11/2025 14:56:00	1330435456012675	XLON
577	1206	10/11/2025 14:56:00	1330435456012677	XLON
180	1206	10/11/2025 14:56:00	1330435456012679	XLON
704	1206	10/11/2025 14:56:00	1330435456012681	XLON
10	1210	10/11/2025 15:13:20	1330435456015137	XLON
170	1210	10/11/2025 15:13:20	1330435456015138	XLON
10	1210	10/11/2025 15:13:20	1330435456015139	XLON
180	1210	10/11/2025 15:13:20	1330435456015140	XLON
180	1210	10/11/2025 15:13:20	1330435456015141	XLON
180	1210	10/11/2025 15:13:20	1330435456015142	XLON
180	1210	10/11/2025 15:13:20	1330435456015143	XLON
180	1210	10/11/2025 15:13:20	1330435456015144	XLON
180	1210	10/11/2025 15:13:20	1330435456015145	XLON
180	1210	10/11/2025 15:13:20	1330435456015146	XLON
180	1210	10/11/2025 15:13:20	1330435456015147	XLON
168	1210	10/11/2025 15:13:20	1330435456015148	XLON
12	1210	10/11/2025 15:13:20	1330435456015149	XLON
168	1210	10/11/2025 15:13:20	1330435456015150	XLON
180	1210	10/11/2025 15:13:20	1330435456015151	XLON
225	1210	10/11/2025 15:13:20	1330435456015152	XLON
180	1210	10/11/2025 15:13:20	1330435456015153	XLON
99	1210	10/11/2025 15:13:20	1330435456015154	XLON
81	1210	10/11/2025 15:13:20	1330435456015155	XLON
180	1210	10/11/2025 15:13:20	1330435456015156	XLON
12	1210	10/11/2025 15:13:20	1330435456015157	XLON
168	1210	10/11/2025 15:17:51	1330435456015845	XLON
1227	1210	10/11/2025 15:17:51	1330435456015846	XLON
465	1210	10/11/2025 15:17:51	1330435456015848	XLON
180	1210	10/11/2025 15:17:51	1330435456015849	XLON
1475	1210	10/11/2025 15:17:51	1330435456015850	XLON
441	1210	10/11/2025 15:17:51	1330435456015851	XLON
198	1210	10/11/2025 15:40:42	1330435456019138	XLON
464	1210	10/11/2025 15:40:42	1330435456019139	XLON
170	1208	10/11/2025 15:52:16	1330435456021147	XLON
168	1208	10/11/2025 15:52:16	1330435456021148	XLON
175	1206	10/11/2025 15:52:31	1330435456021193	XLON
313	1206	10/11/2025 15:52:31	1330435456021194	XLON
72	1210	10/11/2025 16:01:51	1330435456023043	XLON
1098	1208	10/11/2025 16:04:26	1330435456023451	XLON
200	1208	10/11/2025 16:04:26	1330435456023452	XLON
180	1208	10/11/2025 16:24:27	1330435456027673	XLON
86	1208	10/11/2025 16:24:27	1330435456027674	XLON
94	1208	10/11/2025 16:24:27	1330435456027675	XLON
1	1208	10/11/2025 16:24:27	1330435456027676	XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                             +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                         +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                             [email protected]

Ginny Pulbrook                                                                                                                                            +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSGPGUAGUPAGMU